These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15709178)

  • 1. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins.
    Koomen JM; Shih LN; Coombes KR; Li D; Xiao LC; Fidler IJ; Abbruzzese JL; Kobayashi R
    Clin Cancer Res; 2005 Feb; 11(3):1110-8. PubMed ID: 15709178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic protein discovery using proteolytic peptide targeting and identification.
    Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R
    Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery.
    Koomen JM; Li D; Xiao LC; Liu TC; Coombes KR; Abbruzzese J; Kobayashi R
    J Proteome Res; 2005; 4(3):972-81. PubMed ID: 15952745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum protein profiling by miniaturized solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Mohammed S; Bunkenborg J; Kruse TA; Cold S; Mogensen O; Christensen Rd; Vach W; Jørgensen PE; Jensen ON
    Rapid Commun Mass Spectrom; 2005; 19(12):1578-86. PubMed ID: 15915448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
    Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
    J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.
    Koomen JM; Zhao H; Li D; Nasser W; Hawke DH; Abbruzzese JL; Baggerly KA; Kobayashi R
    Rapid Commun Mass Spectrom; 2005; 19(12):1624-36. PubMed ID: 15915451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of intricate kinetics of the serum proteome during and after colon surgery by protein expression time series.
    Roelofsen H; Alvarez-Llamas G; Dijkstra M; Breitling R; Havenga K; Bijzet J; Zandbergen W; de Vries MP; Ploeg RJ; Vonk RJ
    Proteomics; 2007 Sep; 7(17):3219-28. PubMed ID: 17806085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
    Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
    Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A predictive model for pancreatic cancer using serum protein footprint map].
    Long J; Di Y; Jin C; Yu XJ; Liu WW; Chen YM; Fu DL; Ni QX
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1533-6. PubMed ID: 18956633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted protein quantitation and profiling using PVDF affinity probe and MALDI-TOF MS.
    Chen SH; Liao HK; Chang CY; Juo CG; Chen JH; Chan SI; Chen YJ
    Proteomics; 2007 Sep; 7(17):3038-50. PubMed ID: 17676666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplexed immunoassay: quantitation and profiling of serum biomarkers using magnetic nanoprobes and MALDI-TOF MS.
    Wang KY; Chuang SA; Lin PC; Huang LS; Chen SH; Ouarda S; Pan WH; Lee PY; Lin CC; Chen YJ
    Anal Chem; 2008 Aug; 80(16):6159-67. PubMed ID: 18642877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.